About Prometheus Bio (RXDX)
Ignyta, Inc. is a biotechnology company. The Company is focused on precision medicine in oncology. The Company is pursuing an integrated therapeutic (Rx) and companion diagnostic (Dx) strategy for treating cancer patients. The Company's pipeline incl... Read more
- USD107.56
- USD111.59
- USD107.25
- USD129.60
- -8.40%
- 7M
- 355.60k
- 517.19k
- 5.1B
- 21.50
- 171.20%
Stock News
29 minutes ago
The Moneyist: ‘They do not trust her, nor do I’: My elderly parents fear my sister will empty their bank accounts and steal their possessions. What can we do?
MarketWatch
33 minutes ago
Cohen & Steers Closed-End Funds Declare Distributions for April, May, and June 2023
Yahoo
33 minutes ago
Living With Climate Change: Wind damage will impact more U.S. homes than before, in Florida especially. How best to protect your property.
MarketWatch
48 minutes ago
PowerSchool Introduces International Localization Framework to Support Growing Global Customer Base
Yahoo
More Stock Analysis & Reports
Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.
